Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vehreschild

Showing results (161-170 of 221) with videos related to

Pageof 23
Sort By:
Infection|April 15, 2025
Identifying patients at high risk for antibiotic treatment following hospital admission: a predictive score to improve antimicrobial stewardship measuresMoritz Beck, Carolin Koll, Uga Dumpis, et al.
Trials|August 19, 2022
Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients - the randomized, EU-wide, placebo-controlled, phase II study design of IXIONJan Kloka, Benjamin Friedrichson, Stephanie Dauth, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2020
Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross-sectional study in six German university hospitalsAnna M Rohde, Janine Zweigner, Miriam Wiese-Posselt, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR)Vassiliki Dimitriou, Lena M Biehl, Axel Hamprecht, et al.
United European Gastroenterology Journal|April 28, 2022
COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registryJonathan F Brozat, Frank Hanses, Martina Haelberger, et al.
Nature Medicine|September 5, 2022
Long-term cardiac pathology in individuals with mild initial COVID-19 illnessValentina O Puntmann, Simon Martin, Anastasia Shchendrygina, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 15, 2019
Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wardsL M Biehl, P Higgins, T Wille, et al.
Viruses|February 28, 2023
Phage Therapy in Germany-Update 2023Christian Willy, Joachim J Bugert, Annika Y Classen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2024
How to develop a controlled human infection model for Clostridioides difficileAnnefleur D O Hensen, Maria J G T Vehreschild, Dale N Gerding, et al.
Infection|February 10, 2023
Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort studyLisa Pilgram, Katharina S Appel, Maria M Ruethrich, et al.
Pageof 23

Showing results (161-170 of 221) with videos related to

Sort By:
Pageof 23
Infection|April 15, 2025
Identifying patients at high risk for antibiotic treatment following hospital admission: a predictive score to improve antimicrobial stewardship measuresMoritz Beck, Carolin Koll, Uga Dumpis, et al.
Trials|August 19, 2022
Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients - the randomized, EU-wide, placebo-controlled, phase II study design of IXIONJan Kloka, Benjamin Friedrichson, Stephanie Dauth, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2020
Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross-sectional study in six German university hospitalsAnna M Rohde, Janine Zweigner, Miriam Wiese-Posselt, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR)Vassiliki Dimitriou, Lena M Biehl, Axel Hamprecht, et al.
United European Gastroenterology Journal|April 28, 2022
COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registryJonathan F Brozat, Frank Hanses, Martina Haelberger, et al.
Nature Medicine|September 5, 2022
Long-term cardiac pathology in individuals with mild initial COVID-19 illnessValentina O Puntmann, Simon Martin, Anastasia Shchendrygina, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 15, 2019
Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wardsL M Biehl, P Higgins, T Wille, et al.
Viruses|February 28, 2023
Phage Therapy in Germany-Update 2023Christian Willy, Joachim J Bugert, Annika Y Classen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2024
How to develop a controlled human infection model for Clostridioides difficileAnnefleur D O Hensen, Maria J G T Vehreschild, Dale N Gerding, et al.
Infection|February 10, 2023
Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort studyLisa Pilgram, Katharina S Appel, Maria M Ruethrich, et al.
Pageof 23